ICU Medical, Inc. (ICUI)
147.74
+0.52
(+0.35%)
USD |
NASDAQ |
Dec 12, 14:58
ICU Medical Research and Development Expense (Quarterly): 21.25M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Baxter International, Inc. | 115.00M |
| Merit Medical Systems, Inc. | 23.97M |
| TriSalus Life Sciences, Inc. | 5.176M |
| Perspective Therapeutics, Inc. | 19.56M |
| Xtant Medical Holdings, Inc. | 0.634M |